Reactions involving modified oligonucleotides, nucleic acids, or nucleotides

Industry

  • CPC
  • C12Q2525/00
This industry / category may be too specific. Please go to a parent level for more data

Sub Industries

C12Q2525/10Modifications characterised by C12Q2525/101incorporating non-naturally occurring nucleotides C12Q2525/107incorporating a peptide nucleic acid C12Q2525/113incorporating modified backbone C12Q2525/117incorporating modified base C12Q2525/119incorporating abasic sites C12Q2525/121incorporating both deoxyribonucleotides and ribonucleotides C12Q2525/125incorporating agents resulting in resistance to degradation C12Q2525/131incorporating a restriction site C12Q2525/137incorporating/modifying moieties to eliminate restriction sites C12Q2525/143incorporating a promoter sequence C12Q2525/149incorporating a coding sequence C12Q2525/15incorporating a consensus or conserved sequence C12Q2525/151repeat or repeated sequences C12Q2525/155incorporating/generating a new priming site C12Q2525/161incorporating target specific and non-target specific sites C12Q2525/173incorporating a polynucleotide run C12Q2525/179incorporating arbitrary or random nucleotide sequences C12Q2525/185incorporating base(s) where the precise position of the base(s) in the nucleic acid string is important (Not to be used for 3'-end base) C12Q2525/186incorporating a non-extendable or blocking moiety C12Q2525/191incorporating an adaptor C12Q2525/197incorporating a spacer/coupling moiety C12Q2525/203incorporating a composite nucleic acid containing a polypeptide sequence other than PNA C12Q2525/204specific length of the oligonucleotides C12Q2525/205Aptamer C12Q2525/207siRNA, miRNA C12Q2525/30Oligonucleotides characterised by their secondary structure C12Q2525/301Hairpin oligonucleotides C12Q2525/307Circular oligonucleotides C12Q2525/313Branched oligonucleotides

Patents Grantslast 30 patents

Patents Applicationslast 30 patents